急诊科疑似感染患者中Sepsis-3标准的院内死亡预后准确性
该国际前瞻性队列研究于2016年5月至6月在法国、西班牙、比利时和瑞士的30个急诊科进行,连续纳入疑似感染患者,随访至出院或死亡。共筛查1088例,纳入879例分析,中位年龄67岁,47%为女性,43%为呼吸道感染。总体院内死亡率为8%;qSOFA评分低于2分者死亡率为3%,qSOFA评分≥2分者为24%(绝对差21%,95%CI 15%-26%)。qSOFA预测院内死亡的AUROC为0.80(95%CI 0.74-0.85),优于SIRS和严重脓毒症的0.65(95%CI 0.59-0.70)(P<.001;AUROC增量0.15,95%CI 0.09-0.22)。qSOFA评分的死亡风险比为6.2(95%CI 3.8-10.3),严重脓毒症为3.5(95%CI 2.2-5.5)。
要点
- 急诊科疑似感染患者中,qSOFA评分≥2分者院内死亡率为24%,qSOFA评分低于2分者为3%,绝对差21%(95%CI 15%-26%)。
- qSOFA预测院内死亡的AUROC为0.80(95%CI 0.74-0.85),优于SIRS和严重脓毒症的0.65(95%CI 0.59-0.70),P<.001。
- qSOFA评分的死亡风险比为6.2(95%CI 3.8-10.3),严重脓毒症为3.5(95%CI 2.2-5.5)。
- 该研究支持Sepsis-3标准在急诊科用于识别高死亡风险患者。
- 研究为国际前瞻性队列,在30个急诊科连续纳入疑似感染患者,共分析879例。
适用人群与场景
- 2016年5月至6月在法国、西班牙、比利时和瑞士30个急诊科连续就诊的疑似感染患者,共纳入879例分析。
- 中位年龄67岁(四分位距47-81岁),414例(47%)为女性,379例(43%)为呼吸道感染。
诊断标准与关键阈值
- qSOFA评分≥2分定义为高危组,qSOFA评分低于2分为低危组。
- 研究收集了既往和新版脓毒症定义的所有变量,包括qSOFA、SOFA和SIRS。
研究设计与关键结果
- 研究类型为国际前瞻性队列研究,在法国、西班牙、比利时和瑞士的30个急诊科进行,筛查1088例,纳入879例分析。
- 总体院内死亡率为8%;qSOFA评分低于2分者死亡率为3%,qSOFA评分≥2分者为24%,绝对差21%(95%CI 15%-26%)。
- qSOFA预测院内死亡的AUROC为0.80(95%CI 0.74-0.85),SIRS和严重脓毒症均为0.65(95%CI 0.59-0.70),P<.001;AUROC增量为0.15(95%CI 0.09-0.22)。
- qSOFA评分的死亡风险比为6.2(95%CI 3.8-10.3),严重脓毒症为3.5(95%CI 2.2-5.5)。
证据类型、等级与局限
- 证据类型:国际前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急诊科疑似感染患者中,qSOFA评分≥2分提示院内死亡风险较高(24% vs 3%),可帮助识别高危患者。
- qSOFA对院内死亡的预后准确性优于SIRS和严重脓毒症,支持Sepsis-3标准在急诊科使用。
指南或共识出处
- Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: An international task force recently redefined the concept of sepsis. This task force recommended the use of the quick Sequential Organ Failure Assessment (qSOFA) score instead of systemic inflammatory response syndrome (SIRS) criteria to identify patients at high risk of mortality. However, these new criteria have not been prospectively validated in some settings, and their added value in the emergency department remains unknown.
OBJECTIVE: To prospectively validate qSOFA as a mortality predictor and compare the performances of the new sepsis criteria to the previous ones.
DESIGN, SETTINGS, AND PARTICIPANTS: International prospective cohort study, conducted in France, Spain, Belgium, and Switzerland between May and June 2016. In the 30 participating emergency departments, for a 4-week period, consecutive patients who visited the emergency departments with suspected infection were included. All variables from previous and new definitions of sepsis were collected. Patients were followed up until hospital discharge or death.
EXPOSURES: Measurement of qSOFA, SOFA, and SIRS.
MAIN OUTCOMES AND MEASURES: In-hospital mortality.
RESULTS: Of 1088 patients screened, 879 were included in the analysis. Median age was 67 years (interquartile range, 47-81 years), 414 (47%) were women, and 379 (43%) had respiratory tract infection. Overall in-hospital mortality was 8%: 3% for patients with a qSOFA score lower than 2 vs 24% for those with qSOFA score of 2 or higher (absolute difference, 21%; 95% CI, 15%-26%). The qSOFA performed better than both SIRS and severe sepsis in predicting in-hospital mortality, with an area under the receiver operating curve (AUROC) of 0.80 (95% CI, 0.74-0.85) vs 0.65 (95% CI, 0.59-0.70) for both SIRS and severe sepsis (P < .001; incremental AUROC, 0.15; 95% CI, 0.09-0.22). The hazard ratio of qSOFA score for death was 6.2 (95% CI, 3.8-10.3) vs 3.5 (95% CI, 2.2-5.5) for severe sepsis.
CONCLUSIONS AND RELEVANCE: Among patients presenting to the emergency department with suspected infection, the use of qSOFA resulted in greater prognostic accuracy for in-hospital mortality than did either SIRS or severe sepsis. These findings provide support for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) criteria in the emergency department setting.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02738164.
参考来源
- Freund Y, Lemachatti N, Krastinova E, et al. Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department. JAMA. 2017. PMID: 28114554. doi:10.1001/jama.2016.20329
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。